The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells.

In previous studies, we demonstrated that human neuroblastoma cells are equipped with the machinery to direct their homing to bone marrow. These tumor cells express the CXCR4 receptor for the bone marrow stroma-derived chemokine CXCL12 (SDF-1) and secrete the CXCL12 ligand. The present study was undertaken to explore possible differences in gene-expression patterns between neuroblastoma variants that over-express CXCR4 (designated STH cells) and those which express very little of this receptor (STL cells). The results of the study clearly indicate that these variants show a differential gene-expression profile. They differ in expression of some integrins such as VLA2, VLA3 and VLA6, of neuroendocrine-markers such as CD56 and synaptophysin, in the expression of c-kit and in the secretion of certain cytokines and growth factors such as TNFalpha, SDF-1, VEGF, IL-8, GM-CSF and IP-10. We hypothesize that these differences are due to an autocrine SDF-1alpha-CXCR4 axis.

[1]  Gideon Rechavi,et al.  A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma1 , 2001, The Journal of Immunology.

[2]  R. Alon,et al.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. , 2000, Blood.

[3]  D. Taub,et al.  Human Interferon-inducible Protein 10 Is a Potent Inhibitor of Angiogenesis in Vivo , 1995 .

[4]  Roberta Vitali,et al.  c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571 , 2003, International journal of cancer.

[5]  C. Auffray,et al.  Complementary DNA Arrays Identify CD63 Tetraspanin and α3 Integrin Chain as Differentially Expressed in Low and High Metastatic Human Colon Carcinoma Cells , 2002, Laboratory Investigation.

[6]  K. Murphy,et al.  MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells , 2001, British Journal of Cancer.

[7]  P. Leder,et al.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.

[8]  R. Seeger,et al.  Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group , 1994 .

[9]  K. Sugimura,et al.  TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma. , 2000, Anticancer research.

[10]  Irving L. Weissman,et al.  Stem cells [14] , 1991 .

[11]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[12]  M. Burdick,et al.  Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. , 1995, Biochemical and biophysical research communications.

[13]  R. Vessella,et al.  Elevation of cytokine levels in cachectic patients with prostate carcinoma , 2003, Cancer.

[14]  Alberto L. Horenstein,et al.  c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. , 1998, Blood.

[15]  G. Giannelli,et al.  Transforming Growth Factor- (cid:1) 1 Triggers Hepatocellular Carcinoma Invasiveness via (cid:2) 3 (cid:1) 1 Integrin , 2022 .

[16]  M. Ratajczak,et al.  The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells , 2001, Stem cells.

[17]  M. Le Bousse-Kerdilès,et al.  Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. , 2002, Blood.

[18]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[19]  K. Burridge,et al.  Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. , 2001, Current Opinion in Cell Biology.

[20]  G. Nilsson,et al.  Expression and function of chemokine receptors in human multiple myeloma , 2003, Leukemia.

[21]  M. Fukuzawa,et al.  Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. , 2002, Journal of pediatric surgery.

[22]  Evan T Keller,et al.  Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.

[23]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[24]  V. Lee,et al.  Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase‐polymerase chain reaction , 2003, Cancer.

[25]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[26]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.